Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Single Gene Mutation Linked to Severe Atopic Dermatitis

By LabMedica International staff writers
Posted on 05 Jul 2017
A mutation in the CARD11 gene has been linked to the development of the severe allergic skin disease atopic dermatitis (eczema).

The link between the CARD11 mutation and atopic dermatitis was discovered through gene analysis of eight individuals suffering from severe atopic dermatitis from four families. More...
Each of the four families had a distinct mutation that affected a different region of the CARD11 (Caspase recruitment domain-containing protein 11) protein, but all the mutations had similar effects on T-cell signaling.

The CARD11 gene encodes a scaffolding protein involved in lymphocyte receptor signaling. CARDs (Caspase activation and recruitment domains) are interaction motifs found in a wide array of proteins, typically those involved in processes relating to inflammation and apoptosis. These domains mediate the formation of larger protein complexes via direct interactions between individual CARDs. CARD domains are found on a strikingly wide range of proteins, including helicases, kinases, mitochondrial proteins, caspases, and other cytoplasmic factors.

Transfection of the mutant CARD11gene into T-cell lines grown in laboratory culture demonstrated both loss-of-function and dominant-interfering activity upon antigen receptor–induced activation of nuclear factor-kappaB and mammalian target of rapamycin complex 1 (mTORC1). Patient T-cells had similar defects, as well as low production of the cytokine interferon-gamma (IFN-gamma). The mTORC1 and IFN-gamma production defects were partially rescued by supplementation with the amino acid glutamine, which requires CARD11 for import into T-cells.

This study was carried out by the [U.S.] National Institute of Allergy and Infectious Diseases (Bethesda, MD, USA) and was published in the June 19, 2017, online edition of the journal Nature Genetics.

Related Links:
National Institute of Allergy and Infectious Diseases


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.